rs7801661

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015450.3(POT1):​c.1007-205A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.247 in 362,668 control chromosomes in the GnomAD database, including 11,939 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4045 hom., cov: 32)
Exomes 𝑓: 0.27 ( 7894 hom. )

Consequence

POT1
NM_015450.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.497

Publications

9 publications found
Variant links:
Genes affected
POT1 (HGNC:17284): (protection of telomeres 1) This gene is a member of the telombin family and encodes a nuclear protein involved in telomere maintenance. Specifically, this protein functions as a member of a multi-protein complex that binds to the TTAGGG repeats of telomeres, regulating telomere length and protecting chromosome ends from illegitimate recombination, catastrophic chromosome instability, and abnormal chromosome segregation. Increased transcriptional expression of this gene is associated with stomach carcinogenesis and its progression. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
POT1 Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • tumor predisposition syndrome 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • glioma susceptibility 9
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • thyroid gland carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • cerebroretinal microangiopathy with calcifications and cysts 3
    Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 7-124843168-T-C is Benign according to our data. Variant chr7-124843168-T-C is described in ClinVar as Benign. ClinVar VariationId is 677024.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015450.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POT1
NM_015450.3
MANE Select
c.1007-205A>G
intron
N/ANP_056265.2
POT1
NM_001042594.2
c.614-205A>G
intron
N/ANP_001036059.1
POT1
NR_003102.2
n.1570-205A>G
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POT1
ENST00000357628.8
TSL:2 MANE Select
c.1007-205A>G
intron
N/AENSP00000350249.3
POT1
ENST00000607932.5
TSL:1
n.1007-205A>G
intron
N/AENSP00000476506.1
POT1
ENST00000608057.5
TSL:1
n.*104-205A>G
intron
N/AENSP00000476371.1

Frequencies

GnomAD3 genomes
AF:
0.218
AC:
33155
AN:
151938
Hom.:
4048
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.113
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.191
Gnomad ASJ
AF:
0.282
Gnomad EAS
AF:
0.303
Gnomad SAS
AF:
0.184
Gnomad FIN
AF:
0.201
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.283
Gnomad OTH
AF:
0.214
GnomAD4 exome
AF:
0.269
AC:
56572
AN:
210612
Hom.:
7894
Cov.:
3
AF XY:
0.270
AC XY:
29158
AN XY:
107986
show subpopulations
African (AFR)
AF:
0.115
AC:
728
AN:
6334
American (AMR)
AF:
0.186
AC:
1270
AN:
6814
Ashkenazi Jewish (ASJ)
AF:
0.275
AC:
2221
AN:
8062
East Asian (EAS)
AF:
0.331
AC:
6213
AN:
18762
South Asian (SAS)
AF:
0.179
AC:
705
AN:
3936
European-Finnish (FIN)
AF:
0.226
AC:
3434
AN:
15188
Middle Eastern (MID)
AF:
0.281
AC:
322
AN:
1144
European-Non Finnish (NFE)
AF:
0.281
AC:
38301
AN:
136494
Other (OTH)
AF:
0.243
AC:
3378
AN:
13878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1895
3789
5684
7578
9473
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
202
404
606
808
1010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.218
AC:
33142
AN:
152056
Hom.:
4045
Cov.:
32
AF XY:
0.214
AC XY:
15892
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.113
AC:
4692
AN:
41504
American (AMR)
AF:
0.190
AC:
2907
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.282
AC:
980
AN:
3472
East Asian (EAS)
AF:
0.302
AC:
1562
AN:
5164
South Asian (SAS)
AF:
0.185
AC:
888
AN:
4810
European-Finnish (FIN)
AF:
0.201
AC:
2122
AN:
10570
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.283
AC:
19239
AN:
67950
Other (OTH)
AF:
0.213
AC:
449
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1330
2659
3989
5318
6648
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
362
724
1086
1448
1810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.263
Hom.:
4198
Bravo
AF:
0.215
Asia WGS
AF:
0.230
AC:
796
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jun 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.3
DANN
Benign
0.70
PhyloP100
0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7801661; hg19: chr7-124483222; COSMIC: COSV62928764; COSMIC: COSV62928764; API